Mason Capital Management LLC’s Kenneth M Garschina said he wants Grifols SA’s board replaced. The co-founder of the New ...

The Grifols family won’t support a new bid by a third-party to take its namesake drug-maker private amid indications that ...

Link Securities | Grifols (GRF) is in negotiations with banks to refinance bonds maturing next year and a credit line, for a ...

Grifols rejects Brookfield’s €10.5/share offer, signaling undervaluation. Read why GRFS stock is a strong "Buy" despite the ...

Canadian fund Brookfield said on Wednesday it has dropped its plan to take over Spain's Grifols due to a disagreement over ...

基立福（Grifols）近日在西班牙的股票交易中遭遇重创，股价跌幅扩大至10%，刷新了每日最低记录。这一显著下滑反映出投资者对该公司前景的忧虑，尤其是在当前全球医药市场愈发动荡的背景下。

Grifols ends acquisition talks with Brookfield over valuation concerns, highlights strong revenue growth and financial ...

With Spanish plasma specialist Grifols turning down a potential multi-billion-dollar takeover bid, it’s likely back to the ...

周二，德意志银行的一位分析师更新了盖立复（Grifols SA）（GRF:SM）（OTC: GIFOF）的目标价，将其从此前的€9.00上调至€10.00，同时维持对该股的"持有"评级。此次调整是在公司于2024年11月7日公布第三季度业绩后做出的。 分析师指出，对模型的调整较小，盖立复的整体前景保持不变。与同行相比，盖立复的股票正在以折价交易，尽管考虑到公司的债务负担，其EV/EBITDA比率的 ...

Grifols SA’s board of directors said it won’t recommend that shareholders accept Brookfield Asset Management’s indicative ...

Grifols SA’s board recommended that shareholders reject Brookfield Asset Management’s indicative offer, which values the ...

La farmacéutica española Grifols SA está en conversaciones con bancos para refinanciar bonos que vencen el próximo año y ...